By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – German chemical proteomics firm Cellzome said today that it has hit a second milestone in its ongoing epigentics collaboration with GlaxoSmithKline.

The firm did not disclose the amount of the payment, but said that it comes only two months after the firm achieved a first milestone in the collaboration.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.